<DOC>
	<DOCNO>NCT00017511</DOCNO>
	<brief_summary>RATIONALE : Cevimeline may effective treat dry mouth cause radiation therapy head neck cancer . It yet know cevimeline effective therapy treat dry mouth cause radiation therapy . PURPOSE : Randomized phase III trial determine effectiveness cevimeline treat patient dryness mouth cause radiation therapy head neck cancer .</brief_summary>
	<brief_title>Cevimeline Treating Patients With Dry Mouth Caused Radiation Therapy Head Neck Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Compare efficacy cevimeline v placebo , term dryness oral cavity salivary flow , patient xerostomia secondary radiotherapy cancer head neck region . - Assess safety drug patient . OUTLINE : This randomize , double-blind , placebo-controlled , multicenter study . Patients randomize 1 2 treatment arm . - Arm I : Patients receive oral cevimeline 3 time daily 12 week absence unacceptable toxicity . - Arm II : Patients receive oral placebo arm I . PROJECTED ACCRUAL : A total 280 patient ( 140 per arm ) accrue study .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Radiation Injuries</mesh_term>
	<mesh_term>Cevimeline</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Received 4,000 cGy prior external beam radiotherapy cancer head neck region Radiotherapy complete 4 month prior study Clinically significant salivary gland dysfunction grade 2 3 xerostomia At least 1 anatomically intact parotid gland No suspect confirmed bilateral physical closure salivary gland ducts No history primary secondary Sjogren 's syndrome underlying systemic illness know cause xerostomia independent prior radiotherapy exposure PATIENT CHARACTERISTICS : Age : 18 Performance status : Karnofsky 70100 % ECOG 02 Life expectancy : At least 6 month Hematopoietic : Hemoglobin least 9.0 g/dL No anemia Hepatic : Bilirubin great 2 time upper limit normal ( ULN ) SGOT/SGPT great 2 time ULN Lactate dehydrogenase great 2 time ULN No evidence active liver disease Renal : Creatinine great 2.5 mg/dL BUN great 50 mg/dL No history nephrolithiasis within past 6 month Cardiovascular : No history significant cardiovascular disease No active congestive heart failure No uncontrolled angina No significant arrhythmia No myocardial infarction within past 6 month Pulmonary : No history significant pulmonary disease No control uncontrolled asthma No chronic bronchitis chronic obstructive pulmonary disease would limit avocational activity Gastrointestinal : No history significant gastrointestinal disorder No active pancreatic disease No gastroduodenal ulcer within past 6 month No hypersensitive bowel condition require pharmacologic therapy No inflammatory bowel disease No history cholelithiasis within past 6 month ( unless cholecystectomy perform ) Other : No clinically significant laboratory abnormality No history alcohol drug abuse within past 6 month would preclude study No prior concurrent acute iritis narrowangle ( angle closure ) glaucoma Not pregnant Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No concurrent chemotherapy Endocrine therapy : Not specify Radiotherapy : See Disease Characteristics No concurrent radiotherapy Surgery : Not specify Other : At least 30 day since investigational new drug At least 4 week since prior systemic ophthalmic pilocarpine No prior cevimeline No concurrent hyperbaric oxygen therapy No concurrent beta adrenergic antagonist , anticholinergic agent , cevimeline metabolism inhibitor , medication know effect salivary function No concurrent investigational drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>stage I salivary gland cancer</keyword>
	<keyword>stage II salivary gland cancer</keyword>
	<keyword>stage III salivary gland cancer</keyword>
	<keyword>stage IV salivary gland cancer</keyword>
	<keyword>recurrent salivary gland cancer</keyword>
	<keyword>untreated metastatic squamous neck cancer occult primary</keyword>
	<keyword>recurrent metastatic squamous neck cancer occult primary</keyword>
	<keyword>metastatic squamous neck cancer occult primary squamous cell carcinoma</keyword>
	<keyword>oral complication</keyword>
	<keyword>stage I squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage I basal cell carcinoma lip</keyword>
	<keyword>stage I verrucous carcinoma oral cavity</keyword>
	<keyword>stage I mucoepidermoid carcinoma oral cavity</keyword>
	<keyword>stage I adenoid cystic carcinoma oral cavity</keyword>
	<keyword>stage II squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage II basal cell carcinoma lip</keyword>
	<keyword>stage II verrucous carcinoma oral cavity</keyword>
	<keyword>stage II mucoepidermoid carcinoma oral cavity</keyword>
	<keyword>stage II adenoid cystic carcinoma oral cavity</keyword>
	<keyword>stage III squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage III basal cell carcinoma lip</keyword>
	<keyword>stage III verrucous carcinoma oral cavity</keyword>
	<keyword>stage III mucoepidermoid carcinoma oral cavity</keyword>
	<keyword>stage III adenoid cystic carcinoma oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV basal cell carcinoma lip</keyword>
	<keyword>stage IV verrucous carcinoma oral cavity</keyword>
	<keyword>stage IV mucoepidermoid carcinoma oral cavity</keyword>
	<keyword>stage IV adenoid cystic carcinoma oral cavity</keyword>
	<keyword>recurrent squamous cell carcinoma lip oral cavity</keyword>
	<keyword>recurrent basal cell carcinoma lip</keyword>
	<keyword>recurrent verrucous carcinoma oral cavity</keyword>
	<keyword>recurrent mucoepidermoid carcinoma oral cavity</keyword>
	<keyword>recurrent adenoid cystic carcinoma oral cavity</keyword>
	<keyword>stage I squamous cell carcinoma oropharynx</keyword>
	<keyword>stage I lymphoepithelioma oropharynx</keyword>
	<keyword>stage II squamous cell carcinoma oropharynx</keyword>
	<keyword>stage II lymphoepithelioma oropharynx</keyword>
	<keyword>stage III squamous cell carcinoma oropharynx</keyword>
	<keyword>stage III lymphoepithelioma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV lymphoepithelioma oropharynx</keyword>
	<keyword>recurrent squamous cell carcinoma oropharynx</keyword>
	<keyword>recurrent lymphoepithelioma oropharynx</keyword>
	<keyword>stage I squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage I lymphoepithelioma nasopharynx</keyword>
	<keyword>stage II squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage II lymphoepithelioma nasopharynx</keyword>
	<keyword>stage III squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage III lymphoepithelioma nasopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage IV lymphoepithelioma nasopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma nasopharynx</keyword>
	<keyword>recurrent lymphoepithelioma nasopharynx</keyword>
	<keyword>stage I squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage II squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage I squamous cell carcinoma larynx</keyword>
	<keyword>stage I verrucous carcinoma larynx</keyword>
	<keyword>stage II squamous cell carcinoma larynx</keyword>
	<keyword>stage II verrucous carcinoma larynx</keyword>
	<keyword>stage III squamous cell carcinoma larynx</keyword>
	<keyword>stage III verrucous carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
	<keyword>stage IV verrucous carcinoma larynx</keyword>
	<keyword>recurrent squamous cell carcinoma larynx</keyword>
	<keyword>recurrent verrucous carcinoma larynx</keyword>
	<keyword>stage I squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage I invert papilloma paranasal sinus nasal cavity</keyword>
	<keyword>stage I midline lethal granuloma paranasal sinus nasal cavity</keyword>
	<keyword>stage I esthesioneuroblastoma paranasal sinus nasal cavity</keyword>
	<keyword>stage II squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage II invert papilloma paranasal sinus nasal cavity</keyword>
	<keyword>stage II midline lethal granuloma paranasal sinus nasal cavity</keyword>
	<keyword>stage II esthesioneuroblastoma paranasal sinus nasal cavity</keyword>
	<keyword>stage III squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage III invert papilloma paranasal sinus nasal cavity</keyword>
	<keyword>stage III midline lethal granuloma paranasal sinus nasal cavity</keyword>
	<keyword>stage III esthesioneuroblastoma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV invert papilloma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV midline lethal granuloma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV esthesioneuroblastoma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent invert papilloma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent midline lethal granuloma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent esthesioneuroblastoma paranasal sinus nasal cavity</keyword>
	<keyword>radiation toxicity</keyword>
</DOC>